Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy

MT Newswires Live01-08

Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.

Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.

The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.

Price: 337.37, Change: -6.63, Percent Change: -1.93

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2501277695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-08 23:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501277695","market":"sg","top_or_hot":-1,"title":"Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy","media":"MT Newswires Live","content":"<html><body><p> Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.</p><p>Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.</p><p>The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.</p><p>Price: 337.37, Change: -6.63, Percent Change: -1.93</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-08 23:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.Geneoscopy said it plans to use the funding to commercialize its at-...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0006061336.USD","symbol_name":"Blackrock US Small and MidCap Opportunities A2 USD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501277695","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501277695","pubTimestamp":1736349040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.Geneoscopy said it plans to use the funding to commercialize its at-hom","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","BK4121":"生命科学工具和服务","BK4585":"ETF&股票定投概念","BIO.AU":"BIOME AUSTRALIA LTD","LH":"徕博科","BK4550":"红杉资本持仓","BK4588":"碎股","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","BK7111":"个人用品","BIO":"Bio Rad实验室","BK4196":"保健护理服务","BIO.B":"Bio-Rad Laboratories Inc Cl B"},"translate_title":"Bio-Rad Laboratories领投基因镜1.05亿美元C轮融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIO.AU":1,"BIO.B":1,"BIO":0.9,"LH":0.9},"content_text":"Bio-Rad Laboratories (BIO) led the Series C financing round for Geneoscopy, which raised $105 million, the latter said Wednesday.Geneoscopy said it plans to use the funding to commercialize its at-home stool-based colorectal cancer screening test, ColoSense, and continue the development of diagnostic products for inflammatory bowel disease.The gastrointestinal diagnostics development company said investor Labcorp Holdings (LH) will help distribute ColoSense, integrating it into healthcare providers' screening programs.Price: 337.37, Change: -6.63, Percent Change: -1.93","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2501277695"}